The growing organ shortage represents the largest problem in organ transplantation. As a consequence, increased numbers of so-called 'marginal' or extended criteria donor grafts are utilized. Although a common and broadly accepted definition for the term extended criteria donor has not been coined, various donor criteria, including comorbid disease, intensive care treatment, brain death, organ harvesting, and prolonged ischemia have been identified as relevant risk factors. Additionally, increased donor and recipient age have been shown as independent risk factors for the development of chronic graft dysfunction in clinical and experimental studies. 1 Studies in the European-Senior-Program (ESP) suggested that age matching of donor and recipient may have a beneficial effect on graft outcome. The engraftment of kidneys from older donors into elderly recipients with an ameliorated immune response may allow physiological matching. [2] [3] [4] However, our initial clinical experience with grafts from elderly donor grafts and recipients with less potent, calcineurin-inhibitor (CNI)-free immunosuppression demonstrated increased rates of acute rejection episodes requiring frequent conversion to more potent immunosuppressants. 5 Our own previous experimental data revealed an acceleration of chronic graft dysfunction with increasing donor and recipient age. 6 These results may be dependent on a modified immune response in older recipients, particularly during the early post-transplant period. On the other hand, grafts from older donors may elicit an accelerated immune response due to elevated immunogenicity and reduced resistance to unspecific damages.
An increased incidence of acute rejection episodes associated with transplantation of older donor grafts may influence long-term function. [7] [8] [9] In addition, a reduced capability for repair and renewal of damaged tissue may result in a persistent inflammation in parallel to increased antigen recognition. [10] [11] [12] [13] Moreover, several clinical and experimental studies demonstrated an increased allostimulation by 'aged' antigen-presenting cells (APC) and enhanced immune responses following the contact with aged APC. 14, 15 In the current study, we dissected the effects of donor age on graft immunogenicity and consecutive alterations of the recipient's immune response in an established experimental kidney transplantation model.
RESULTS
Recipients of grafts from both young and old donors survived the observation period. To correlate age-related physiological changes with alterations in age-matched allografts, we measured the increment of functional/structural deterioration.
Renal function
Proteinuria in old native uni-nephrectomized controls increased twofold over the 6 months observation period, while rising almost fivefold during this time period in older allografts (increase: P ¼ 0.0003; old vs young allograft by month 6: P ¼ 0.0015; Figure 1 , Table 1 ). In contrast, proteinuria remained stable in both, young native controls and recipients of young donor grafts (P ¼ NS).
Creatinine clearance (CL) was significantly lower in recipients of older donor grafts at the end of the observation period (P ¼ 0.0093), whereas no significant differences were observed between young and old nephrectomized controls (Table 1) .
Morphology
Morphological criteria were not significantly different between 3-and 18-month-old native controls. However, the ratio of structural changes had significantly progressed in older donor grafts/older age-matched native controls vs younger donor grafts/younger age-matched controls (Figure 2a-d, Table 1 ).
Alloantigen-specific intracellular IFN-c secretion enzyme-linked immunosorbent assay
The immune response of recipients of elderly donor grafts was more intense than that of recipients of younger donor grafts. Although levels of intracellular interferon (IFN)-g increased during the observation period in both recipients of young and old donors, grafts from older donors elicited higher frequencies of alloreactive T cells (P ¼ 0.0022 by month 1, and P ¼ 0.04 by month 3, respectively; Figure 3 ).
Cytokine production after in vitro stimulation of splenocytes ELISA Production of interleukin (IL)-2, IFN-g, IL-4, and IL-10 was significantly elevated in recipients of old donor grafts early after transplantation (by 1 month: IL-2: Po0.0001;. IFN-g: Po0.0001; IL-4: P ¼ 0.0027; IL-10: Po0.0001). However, at the end of the observation period levels for IFN-g and IL-4 had increased in recipients of young donor grafts (IFN-g: P ¼ 0.0128; IL-4: P ¼ 0.0045; Figure 4 ).
T-cell subsets, B cells, and DC in peripheral organs
Recipients of older donor grafts displayed significantly increased amounts of CD3 þ CD4 þ T cells in spleens early after transplantation (P ¼ 0.028 and 0.017 by days 5 and 10, respectively). In parallel, CD3 þ CD8 þ cells had increased in peripheral blood and spleens in recipients of elderly donor grafts (P ¼ 0.0012 and 0.0535, respectively, by day 3; data not shown). Peripheral blood immunoglobulin (Ig)k þ B cells had significantly increased in recipients of older donor grafts at early time intervals (P ¼ 0.0001 by day 5, and P ¼ 0.0049 by 1 month, respectively; Figure 5 ). By 6 months, however, frequencies of T and B cells were comparable in all compartments. The presence of dendritic cells (DC) in peripheral compartments (spleen, lymph nodes, blood) was not influenced by donor age at any time.
Graft-infiltrating cells
Intragraft OX62 þ DC were elevated in recipients of elderly grafts at early time intervals (P ¼ 0.011 and 0.016 by day 3 and 1 month, respectively). At later time intervals (3 and 6 months) frequencies of intragraft DC were not different in young and old donor transplants ( Figure 6 ). The majority of graft-infiltrating cells expressing high levels of major histocompatibility complex (MHC) class II and the costimulatory molecule CD86 were found within the Igk þ B-cell population. These cells were significantly In contrast, after 6 months levels of IFN-g and IL-4 had increased in recipients of grafts from young donors, whereas the production of IL-2 and IL-10 was comparable in both study groups at the end of the observation period.
increased in grafts from older donors (Igk þ B cells, P ¼ 0.001 and 0.065; Igk þ MHC class II þ cells, P ¼ 0.035 and 0.063; Igk þ CD86 þ cells, P ¼ 0.009 and 0.022, by days 3 and 5, respectively; Figure 7a -c). Intragraft B cells peaked by day 10 in both, recipients of young and old donor grafts, albeit not showing quantitative significant differences at that time, and declined significantly at later time intervals (Po0.05). The endothelial marker platelet-endothelial cell adhesion molecule (PECAM)-1 (CD31) was significantly higher expressed in older donor grafts early after transplantation (CD31 þ cells, P ¼ 0.0016, and CD31 þ MHC class II þ cells, P ¼ 0.0008 by day 3, not shown).
Thus, overall graft-infiltrating cells and activation markers were more pronounced early after transplantation in kidneys from older donors, whereas stronger in younger donor kidneys at later time intervals.
DISCUSSION
Donor age is an important predictor of long-term graft outcome. 10, 16, 17 Grafts from older donors demonstrate an increased incidence of acute rejection episodes in the early post-transplantation period [7] [8] [9] 18 leading to subsequent chronic graft deterioration. Pre-existing donor criteria such as age, previous diseases, and brain death as well as perioperative injuries may influence long-term graft survival in an antigen-independent, nonspecific manner. 19 The aging process causes important changes that result in a diminution of the functional reserve and inability to respond adequately to stress conditions. 10, 20 Recently, Halloran et al. 10 introduced the term 'senescence', a normal process in the cell cycle to sort out exhausted cells and prevent malignant mutations. Recent studies on cell biology, aging, and senescence described the limitation of cell cycles of somatic cells and telomere shortening with age in humans. These processes, which finally lead to the shut down of the cell, may play an important role in cellular senescence and may explain the incompetence of aged organs to repair damaged tissue. 10, 11 Indeed, grafts from older donors show an impaired ability to repair injured tissue, which in turn may lead to persisting inflammation and increased immune recognition. Previously, Melk et al. 21 described mechanisms of cell senescence in aged rat kidneys independent of telomere shortening, which may contribute to nephron shutdown and an age-related pathology of rat kidneys. In keeping with the observation that immunosenescence and many conditions leading to end stage renal disease share common features of functional and structural decline, agerelated progressive fibrosis of both interstitium and glomeruli may lead to enhanced infiltration of immune cells, thereby promoting a proinflammatory environment. 10, 22 Besides, primarily cortical loss of functional nephrons and increased vascular resistance might further contribute to hyperfiltration and proteinuria, which in turn lead to tubular cell activation, gene expression of inflammatory mediators, and ongoing immune response in aged kidneys. Accordingly, 18-monthold rats displayed an almost normal GFR followed by a continuously regressive filtration rate and total loss of functional reserve beyond this age. 23 Thus, it can be hypothesized that immunosenescence and functional alterations with advancing age act synergistically in stimulating unspecific inflammation, progressive functional loss, and immune recognition. In regard to the 'injury response', antigens expressed on injured grafts are more likely to activate and provoke an immune response. 9 This process is associated with increased expression of proinflammatory cytokines, MHC antigens, and increased recruitment and activation of APC. 12, 13 Several clinical and experimental studies report on an increased allostimulation by aged APC and enhanced immune responses following the contact with 'aged' APC. 14, 15 DC are the most potent stimulators of T cells and are responsible for initiating an immune response by alloantigen presentation to naive T cells. Several authors previously reported an impaired production of IL-1 by peritoneal APC, 24 altered levels of macrophage products, 25 and dysregulation of macrophage-derived IL-12, IL-10, and IFN-g production with increasing age. 26, 27 In addition, an age-related impaired T-cell proliferation associated with enhanced APC function and increased production of IL-10 and IL-12 has been reported. 15, 28 Chronic allograft deterioration is a multi-faceted process. The F-344 -Lewis (LEW) kidney transplant model has been used before by us and others to study the events of this process. 29, 30 This model has been characterized with differences in two MHC class I loci and various non-MHC genes. An initial immunosuppression is necessary in this model to suppress early acute rejection episodes. However, long-term immunosuppression is not applied, thus differing from the clinical situation.
Our experimental data demonstrate the induction of a strong immune response in the early post-transplantation period after engraftment of aged donor kidneys leading to long-term functional and structural deterioration. While a restricted physiological capacity of older grafts has been assumed, we were able to show a modified immune response with increasing donor age.
Although early functional measurements were not obtained in our current experiment, donor age did not impact early renal function (by 2 weeks) in a previous study. 19 Thus, senescence rather than consequences of unspecific injuries associated with ischemia or delayed graft function (DGF) 31, 32 seems to be causative for the modified immune response observed in our model.
Alloreactive T cells increased during the observation period in both recipients of young and old donor grafts. However, T-cell alloreactivity was significantly elevated in young recipients of old grafts after allospecific in vitro stimulation with splenocytes of donor origin. Recipients of older donor grafts demonstrated increased levels of IL-2, IFN-g, IL-4, and IL-10 early after transplantation. At the end of the observation period, levels were comparable (IL-2, IL-10) or showed a significant increase (IFN-g, IL-4) in recipients of young grafts at this time. T cell (CD3, CD4, CD8) and Igk þ B cell counts were significantly elevated in peripheral compartments early post-transplantation when kidneys from older donors were engrafted accompanied by higher frequencies of intragraft OX62 þ DC. Again, those differences declined by the end of the observation period.
Furthermore, we observed a strong intragraft B-cell accumulation in older grafts early after transplantation with a strong expression of MHC class II, the costimulatory molecule CD86, and high frequencies of intragraft CD31 þ MHC class II þ cells.
These effects may be related to an age-associated increase in graft immunogenicity.
Thus, further investigations have to focus on the mode of antigen presentation and the role of 'passenger leukocytes' within the 'old' graft potentially provoking a subsequent stronger T-cell immune response in the young recipient.
Recognition of foreign antigens can occur by two distinct, but not exclusive pathways. The direct pathway represents the recognition of foreign MHC molecules on the surface of donor APC. The indirect pathway occurs when donor MHC molecules are internalized, processed, and presented to alloreactive T cells by host APC. 33 There is evidence that donor DC ('passenger leukocytes') promote graft acceptance by the indirect pathway. On the other hand, donor DC were suggested to increase graft immunogenicity and to trigger acute rejection by the direct pathway. 34 The primary presentation of donor antigen by the direct pathway in combination with 'aged' donor-derived APC may lead to an enhanced immune response, particular during the early period after transplantation. It can be speculated that donorderived APC will be depleted from the transplanted organ within weeks after transplantation, whereas recipient APC permanently migrate through the graft.
In fact, our own results demonstrated an increase in T-cell alloreactivity, cytokine production and higher numbers of peripheral T and B cells early after transplantation in recipients of older grafts, whereas differences in the immune response to young vs old grafts were diminished at later time points.
An interesting finding in our study was the presence of an increased B-cell infiltration in grafts from older donors. Recent clinical studies described dense clusters of B cells in kidney graft biopsies strongly associated with both severity and steroid resistance of rejection episodes, suggesting an important role of infiltrating B cells in acute rejection and graft outcome. 35, 36 Moreover, a recent case report presented data on acute rejection episodes with increased frequencies of CD20 þ B cell infiltrates refractory to standard immunosuppressive therapy. Consequently, graft function had improved after treatment with rituximab, a humanized anti-CD20 monoclonal antibody (mAb). 37, 38 B-cell infiltration was not correlated with humoral-mediated graft injury as elevated levels of Ig or complement deposits were absent. 35 Recent studies by Steinmetz et al. 39 propose that CXCL13mediated attraction of CXCR5-expressing B cells into rejecting allografts play a crucial role in B-cell cluster formation and predict chronic allograft rejection. However, the functional relevance of intragraft B cells needs further investigation. Besides the production of alloantibodies, B cells may play a pivotal role as APC in indirect antigen recognition.
An additional finding in our studies was the high intragraft frequency of CD31 þ MHC class II þ cells shortly after transplantation of aged grafts in young recipients. The CD31 mAb stains for the PECAM-1, which is expressed by endothelial cells, platelets, monocytes, neutrophils, and certain T-cell subsets and is involved in acute and chronic allograft rejection via its effects on leukocyte trafficking. [40] [41] [42] MHC class II molecules are upregulated on endothelial cells in allografts. Interaction between alloreactive CD4 þ T cells and activated endothelial cells expressing MHC class II may play a role in recruitment of leukocytes into vascularized allografts and may provide antigen-dependent signals through the direct pathway. [42] [43] [44] Indeed, increased intragraft PECAM-1 (CD31) and MHC class II expression in older grafts was associated with enhanced leukocyte infiltration (T cells, B cells, and DC) in our experiments. Although previous studies showed an increased expression of PECAM-1 on monocytes and leukocyte function-associated molecule-1 (CD11a) on lymphocytes with increasing age, 45 others report on age-related declines in numbers of blood mononuclear and vascular endothelial cells, structural and functional alterations, and a senescence-associated decline of lymphocyte migration. [46] [47] [48] In conclusion, our results suggest that grafts from older donors are more immunogenic and therefore recipients of aged kidneys may require a more intense immunosuppression in the early period after transplantation. Donor treatment may be particularly beneficial in older grafts.
MATERIALS AND METHODS The transplantation model
Male inbred rats (Harlan Winkelmann, Borchen, Germany) were used throughout the experiments. Kidneys from young and old Fischer 344 rats (F-344, RT1 1v1 , 3-month-old, 235730 g, and 18-month-old, 430730 g, respectively) were transplanted into LEW recipients (RT1 1 , 3-month-old, 275740 g) using standard microsurgical techniques (anastomosis time 2575 min). One native kidney was removed during transplantation, and the remaining kidney 10 days later; cyclosporine A treatment was given for 10 days at a dosage of 1.5 mg/kg/day to prevent initial acute rejection episodes. Before organ harvesting, grafts were perfused with University of Wisconsin solution and kept at 41C for 5 min. Graft survival and renal function (urinary protein excretion, creatinine clearance) were monitored for 6 months. Data were compared with native, uni-nephrectomized young and old controls to distinguish age-related physiological changes at the beginning (3 and 18 months) and at the end of the observation period (9 and 24 months), respectively. Donor age-related immune response was analyzed sequentially in graft sections, blood samples, and spleen of allograft recipients taken by 3, 5, 10 days and 1, 3, and 6 months (n ¼ 6/group).
All animal experiments were performed with the permission of the local authorities (Landesamt für Gesundheitsschutz, Arbeitsschutz und Technische Sicherheit, Berlin, Germany, Project-No.: G 0096/03).
Renal function
Serum and urine samples were collected in all groups. Creatinine clearance was tested at monthly intervals and calculated as: urine creatinine (mg/ml) Â urine volume (ml)/serum creatinine (mg/ml) Â time of urine collection (min).
Protein excretion (mg/24 h) was measured by precipitation with 20% CCl 3 COOH. Turbidity was assessed at a wavelength of 415 nm using a Hitachi 911 analyzer.
Proteinuria, the most sensitive parameter for chronic renal allograft nephropathy in rat models, 49 was tested at similar intervals. The relative increase in urinary protein excretion between 1 and 6 months was calculated in recipients of grafts from older vs younger donors and compared with the increase in protein excretion in agematched unilaterally nephrectomized controls.
Morphological analysis
Structural changes in allografts were compared with native kidneys in age-matched uni-nephrectomized controls. Specimens were fixed in 4% buffered formalin, paraffin embedded, stained with hematoxylin and eosin, and assessed by light microscopy. To determine the extent of glomerulosclerosis, the number of glomeruli per kidney section were counted and the ratio was expressed as a percentage of affected to normal glomeruli. The extent of arteriosclerosis, cellular infiltrates, tubular atrophy, and interstitial fibrosis was quantified on a 0 to 4 þ scale (4 þ ¼ greatest structural deterioration / 420 fields of view per section were evaluated at Â 200).
Flow cytometry
Heparinized blood and biopsies of spleen and graft sections were obtained from LEW recipients at sequential time intervals. Graft sections were pretreated with collagenase IV (1%/RPMI) for 30 min. Peripheral blood mononuclear cells, splenocytes, and graft-infiltrating cells were isolated by a standard procedure using Pancoll TM density gradient centrifugation (density 1.091 g/ml; Pan Biotech GmbH, Aidenbach, Germany). After isolation, cells were resuspended in RPMI 1640 containing 10% fetal calf serum, 1% glutamine, and 1% penicillin/streptomycin at a concentration of 5 Â 10 6 cells/ml. Aliquots (400 ml) of the cell suspension were distributed for staining.
Mouse anti-rat mAbs (BD PharMingen GmbH, Heidelberg, Germany; Biocarta Europe GmbH, Hamburg, Germany) used included CD3-PE (IF4, T cells), CD4-APC (W3/25, T-helper cells), CD8-PerCP (OX-8, cytotoxic T cells), Igk-fluorescein isothiocyanate (OX-12, Pan-B cells), OX-62-PE (OX-62, rat DC), CD86-PE (24F, B7-2, activated B cells, and monocytes), MHC class II-PerCP (OX-6, RT1B, activated APC), and CD31-PE (TLD-3A12, platelet endothelial cellular adhesion molecule/PECAM-1, leukocytes, and endothelial cells).
Fixed and stained lymphocyte samples were analyzed with a FACScalibur, (Becton Dickinson, Palo Alto, CA) and analyzed with CELLQuest software. The cytometer was calibrated with CaliBRITE1 beads (Becton Dickinson, USA) using FACSComp software and with QC-3 beads according to the manufacturer's recommendations (Flow Cytometry Standards Corp., San Juan, Puerto Rico). A total of 500 000 events were acquired.
In vitro stimulation of rat splenocytes Single cell suspensions of splenocytes were prepared in RPMI medium with 10% fetal calf serum and dispensed into 24-well plates at a concentration of 1 Â 10 7 /well. Cells were stimulated with Lipopolysaccharide (LPS: 10 mg/ml), Concavalin A (ConA: 5 mg/ml) for 5 h or phorbol 12-myristate 13-acetate (PMA 2 ng/ml)/ ionomycin (1 mg/ml) for 24 h at 371C. Unstimulated rat spleen cells served as controls. Supernatants of spleen cell cultures were tested for IL-2, IFN-g, IL-4, and IL-10 using enzyme-linked immunosorbent assay kits as recommended by the manufacturer (OptEIA TM Set, Pharmingen, San Diego, CA, USA).
Alloreactive ELISPOT
The frequency of alloreactive T cells was determined in LEW recipients using a rat IFN-g ELISPOT assay (Diaclone, Besanc¸on Cedex, France). Rat spleen cells were prepared as described above. Briefly, polyvinylidine difluoride (PVDF)-bottomed 96-well microtiter plates (Diaclone) were incubated with 70% ethanol for 10 min. Plates were incubated with an anti-rat IFN-g capture antibody for 12 h; unspecific binding was blocked with 2% skimmed dry milk in phosphate-buffered saline. Subsequently, RPMI medium (negative control), PMA (2 ng/ml/2 mg/ml, both Sigma Aldrich GmbH, Munich, Germany), or 5 Â 10 5 stimulator cells (F-344 splenocytes) were dispensed into the wells. Thereafter, 5 Â 10 5 responder cells (LEW splenocytes) were added. Plates were incubated for 24 h, washed and incubated with a biotinylated anti-rat IFN-g detection antibody for 3 h. After a final 45 min incubation period with a streptavidin-alkaline phosphatase conjugate and subsequent administration of the staining buffer (BCTP/NTB; Diaclone), plates were dried and alloreactive T cells were measured using the BIOREA-DER s 3000 C/BIOCOUNTER system (BIOREADER 3000 C, BIO-SYS GmbH, Karben, Germany). The actual frequency was determined as a ratio of the number of spots/number of responder cells. This ratio was then adapted to the actual percentage of T cells in the responder cell preparation assessed by flow cytometry. 50 
Statistics
Data were expressed as mean7s.e. for comparison using unpaired t-test or Mann-Whitney Test, respectively. Statistical difference was accepted at Po0.05.
